Brown M A, Buddle M L, Farrell T, Davis G, Jones M
Department of Renal Medicine, St George Hospital, University of New South Wales, Kogarah, Australia.
Lancet. 1998 Sep 5;352(9130):777-81. doi: 10.1016/S0140-6736(98)03270-X.
There is debate about whether diastolic blood pressure should be recorded as the fourth (muffling, K4) or fifth (disappearance, K5) Korotkoff sound in pregnancy. We compared maternal and fetal outcomes and the likelihood that episodes of severe hypertension would be recorded when hypertensive pregnancies were managed according to either K4 or K5.
220 pregnant women with diastolic hypertension (K4 > or =90 mm Hg) after the 20th week of gestation were enrolled in a prospective randomised study at two obstetric units in Australia; they were randomly assigned management with K4 (n=103) or K5 (n=117) for the remainder of the pregnancy. Clinical management was according to a uniform department protocol. Analysis was by intention to treat. All the women completed the trial.
An episode of severe hypertension (systolic > or =170 mm Hg, diastolic > or =110 mm Hg, or both) was more likely to be recorded with use of K4 than with use of K5 (39 [38%] vs 30 [26%] women, p=0.051), mainly because of a greater likelihood that severe diastolic hypertension would be recorded (34 [33%] vs 20 [17%], p=0.006). The frequency of severe systolic hypertension and simultaneous severe systolic and diastolic hypertension did not differ between groups. Pregnancy was prolonged by an average of 2 weeks in both groups, and there were no significant differences between the groups in laboratory data, requirements for antihypertensive treatment, birthweight, fetal growth retardation, or perinatal mortality. There was no eclampsia or significant maternal morbidity in either group.
A change from use of K4 to K5 would mean that one fewer case of severe diastolic hypertension would be recorded for every six hypertensive pregnancies, but all other episodes of severe hypertension would be recorded with similar frequency. Since the K4/K5 difference is smaller in hypertensive than in normotensive pregnant women and since K5 is closer to the actual intra-arterial pressure and more reliably detected, universal adoption of K5 to record diastolic blood pressure in hypertensive pregnancy should be considered.
关于孕期舒张压应记录为第四期(柯氏音减弱,K4)还是第五期(柯氏音消失,K5)存在争议。我们比较了采用K4或K5管理高血压孕妇时的母婴结局以及记录严重高血压发作的可能性。
220名妊娠20周后出现舒张压高血压(K4≥90mmHg)的孕妇在澳大利亚的两个产科单位参加了一项前瞻性随机研究;她们在孕期剩余时间被随机分配采用K4(n = 103)或K5(n = 117)进行管理。临床管理遵循统一的科室方案。分析采用意向性分析。所有女性均完成了试验。
采用K4记录时,严重高血压发作(收缩压≥170mmHg,舒张压≥110mmHg,或两者兼有)的记录可能性高于采用K5记录时(39名[38%]对30名[26%]女性,p = 0.051),主要是因为记录严重舒张压高血压的可能性更大(34名[33%]对20名[17%],p = 0.006)。两组间严重收缩期高血压以及同时出现严重收缩期和舒张期高血压的频率无差异。两组孕期均平均延长2周,两组在实验室数据、降压治疗需求、出生体重、胎儿生长受限或围产儿死亡率方面无显著差异。两组均未发生子痫或严重母体并发症。
从采用K4改为K5意味着每6例高血压孕妇中严重舒张压高血压的记录病例数将减少1例,但所有其他严重高血压发作的记录频率相似。由于高血压孕妇中K4/K5的差异小于正常血压孕妇,且K5更接近实际动脉内压且检测更可靠,应考虑普遍采用K5来记录高血压孕妇的舒张压。